ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026

Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas.

Damien Sanogo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.